Our
Publications
CADAP
European Drug Report 2021: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug...
EMCDDA initial report on the new psychoactive substance 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC)
3-MMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2012. Based on...
Risk assessment of new psychoactive substances (NPS)
Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to...
Penalties for drug law offences at a glance
On this page you can examine and compare the penalties, or rehabilitative responses, for the core offences of drug use, possession for personal use, and...
